Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up.

Videla S, Tarrats A, Ornelas A, Badia R, Castella E, Alcalde C, Chamorro A, Esté JA, Clotet B, Sirera G.

Int J STD AIDS. 2018 Aug 31:956462418792653. doi: 10.1177/0956462418792653. [Epub ahead of print]

PMID:
30170532
2.

Special delivery: scavengers direct seed dispersal towards ungulate carcasses.

Steyaert SMJG, Frank SC, Puliti S, Badia R, Arnberg MP, Beardsley J, Økelsrud A, Blaalid R.

Biol Lett. 2018 Aug;14(8). pii: 20180388. doi: 10.1098/rsbl.2018.0388.

PMID:
30111659
3.

CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.

Badia R, Ballana E, Castellví M, García-Vidal E, Pujantell M, Clotet B, Prado JG, Puig J, Martínez MA, Riveira-Muñoz E, Esté JA.

Nat Commun. 2018 Jul 16;9(1):2739. doi: 10.1038/s41467-018-05157-w.

4.

ADAR1 affects HCV infection by modulating innate immune response.

Pujantell M, Franco S, Galván-Femenía I, Badia R, Castellví M, Garcia-Vidal E, Clotet B, de Cid R, Tural C, Martínez MA, Riveira-Muñoz E, Esté JA, Ballana E.

Antiviral Res. 2018 Aug;156:116-127. doi: 10.1016/j.antiviral.2018.05.012. Epub 2018 Jun 12.

PMID:
29906476
5.

Publisher Correction: Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes.

Bonàs-Guarch S, Guindo-Martínez M, Miguel-Escalada I, Grarup N, Sebastian D, Rodriguez-Fos E, Sánchez F, Planas-Fèlix M, Cortes-Sánchez P, González S, Timshel P, Pers TH, Morgan CC, Moran I, Atla G, González JR, Puiggros M, Martí J, Andersson EA, Díaz C, Badia RM, Udler M, Leong A, Kaur V, Flannick J, Jørgensen T, Linneberg A, Jørgensen ME, Witte DR, Christensen C, Brandslund I, Appel EV, Scott RA, Luan J, Langenberg C, Wareham NJ, Pedersen O, Zorzano A, Florez JC, Hansen T, Ferrer J, Mercader JM, Torrents D.

Nat Commun. 2018 May 30;9(1):2162. doi: 10.1038/s41467-018-04170-3.

6.

Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes.

Bonàs-Guarch S, Guindo-Martínez M, Miguel-Escalada I, Grarup N, Sebastian D, Rodriguez-Fos E, Sánchez F, Planas-Fèlix M, Cortes-Sánchez P, González S, Timshel P, Pers TH, Morgan CC, Moran I, Atla G, González JR, Puiggros M, Martí J, Andersson EA, Díaz C, Badia RM, Udler M, Leong A, Kaur V, Flannick J, Jørgensen T, Linneberg A, Jørgensen ME, Witte DR, Christensen C, Brandslund I, Appel EV, Scott RA, Luan J, Langenberg C, Wareham NJ, Pedersen O, Zorzano A, Florez JC, Hansen T, Ferrer J, Mercader JM, Torrents D.

Nat Commun. 2018 Jan 22;9(1):321. doi: 10.1038/s41467-017-02380-9. Erratum in: Nat Commun. 2018 May 30;9(1):2162.

7.

RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.

Pujantell M, Riveira-Muñoz E, Badia R, Castellví M, Garcia-Vidal E, Sirera G, Puig T, Ramirez C, Clotet B, Esté JA, Ballana E.

Sci Rep. 2017 Oct 17;7(1):13339. doi: 10.1038/s41598-017-13580-0.

8.

Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.

Garcia-Vidal E, Castellví M, Pujantell M, Badia R, Jou A, Gomez L, Puig T, Clotet B, Ballana E, Riveira-Muñoz E, Esté JA.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01368-17. doi: 10.1128/AAC.01368-17. Print 2017 Nov.

9.

A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients.

Grau-Expósito J, Serra-Peinado C, Miguel L, Navarro J, Curran A, Burgos J, Ocaña I, Ribera E, Torrella A, Planas B, Badía R, Castellví J, Falcó V, Crespo M, Buzon MJ.

MBio. 2017 Jul 11;8(4). pii: e00876-17. doi: 10.1128/mBio.00876-17.

10.

Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.

Famiglini V, La Regina G, Coluccia A, Masci D, Brancale A, Badia R, Riveira-Muñoz E, Esté JA, Crespan E, Brambilla A, Maga G, Catalano M, Limatola C, Formica FR, Cirilli R, Novellino E, Silvestri R.

J Med Chem. 2017 Aug 10;60(15):6528-6547. doi: 10.1021/acs.jmedchem.6b01906. Epub 2017 Jul 5.

PMID:
28628334
11.

Antiviral treatment strategies based on gene silencing and genome editing.

Badia R, Ballana E, Esté JA, Riveira-Muñoz E.

Curr Opin Virol. 2017 Jun;24:46-54. doi: 10.1016/j.coviro.2017.04.001. Epub 2017 Apr 21. Review.

PMID:
28437703
12.

SAMHD1 is active in cycling cells permissive to HIV-1 infection.

Badia R, Pujantell M, Torres-Torronteras J, Menéndez-Arias L, Martí R, Ruzo A, Pauls E, Clotet B, Ballana E, Esté JA, Riveira-Muñoz E.

Antiviral Res. 2017 Jun;142:123-135. doi: 10.1016/j.antiviral.2017.03.019. Epub 2017 Mar 28.

PMID:
28359840
13.

The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells.

Badia R, Pujantell M, Riveira-Muñoz E, Puig T, Torres-Torronteras J, Martí R, Clotet B, Ampudia RM, Vives-Pi M, Esté JA, Ballana E.

PLoS Pathog. 2016 Aug 19;12(8):e1005829. doi: 10.1371/journal.ppat.1005829. eCollection 2016 Aug.

14.

Long-term HIV-1 infection induces an antiviral state in primary macrophages.

Pujantell M, Badia R, Ramirez C, Puig T, Clotet B, Ballana E, Esté JA, Riveira-Muñoz E.

Antiviral Res. 2016 Sep;133:145-55. doi: 10.1016/j.antiviral.2016.08.004. Epub 2016 Aug 7.

PMID:
27510577
15.

Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.

Brai A, Fazi R, Tintori C, Zamperini C, Bugli F, Sanguinetti M, Stigliano E, Esté J, Badia R, Franco S, Martinez MA, Martinez JP, Meyerhans A, Saladini F, Zazzi M, Garbelli A, Maga G, Botta M.

Proc Natl Acad Sci U S A. 2016 May 10;113(19):5388-93. doi: 10.1073/pnas.1522987113. Epub 2016 Apr 26.

16.

Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitors.

Camarasa M, Puig de la Bellacasa R, González ÀL, Ondoño R, Estrada R, Franco S, Badia R, Esté J, Martínez MÁ, Teixidó J, Clotet B, Borrell JI.

Eur J Med Chem. 2016 Jun 10;115:463-83. doi: 10.1016/j.ejmech.2016.03.055. Epub 2016 Mar 21.

PMID:
27054294
17.

Nitrogen positional scanning in tetramines active against HIV-1 as potential CXCR4 inhibitors.

Puig de la Bellacasa R, Gibert A, Planesas JM, Ros-Blanco L, Batllori X, Badía R, Clotet B, Esté J, Teixidó J, Borrell JI.

Org Biomol Chem. 2016 Jan 28;14(4):1455-1472. doi: 10.1039/c5ob02419f. Epub 2015 Dec 21.

PMID:
26691389
18.

Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1.

Badia R, Angulo G, Riveira-Muñoz E, Pujantell M, Puig T, Ramirez C, Torres-Torronteras J, Martí R, Pauls E, Clotet B, Ballana E, Esté JA.

J Antimicrob Chemother. 2016 Feb;71(2):387-94. doi: 10.1093/jac/dkv363. Epub 2015 Nov 4.

19.

The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent.

Badia R, Grau J, Riveira-Muñoz E, Ballana E, Giannini G, Esté JA.

Antiviral Res. 2015 Nov;123:62-9. doi: 10.1016/j.antiviral.2015.09.004. Epub 2015 Sep 5.

PMID:
26348004
20.

Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages.

Ruiz A, Pauls E, Badia R, Torres-Torronteras J, Riveira-Muñoz E, Clotet B, Martí R, Ballana E, Esté JA.

Cell Cycle. 2015;14(11):1657-65. doi: 10.1080/15384101.2015.1030558.

21.

Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.

Famiglini V, La Regina G, Coluccia A, Pelliccia S, Brancale A, Maga G, Crespan E, Badia R, Riveira-Muñoz E, Esté JA, Ferretti R, Cirilli R, Zamperini C, Botta M, Schols D, Limongelli V, Agostino B, Novellino E, Silvestri R.

J Med Chem. 2014 Dec 11;57(23):9945-57. doi: 10.1021/jm5011622. Epub 2014 Nov 24.

PMID:
25418038
22.

Characterization of the influence of mediator complex in HIV-1 transcription.

Ruiz A, Pauls E, Badia R, Riveira-Muñoz E, Clotet B, Ballana E, Esté JA.

J Biol Chem. 2014 Oct 3;289(40):27665-76. doi: 10.1074/jbc.M114.570341. Epub 2014 Aug 6.

23.

Increased expression of SAMHD1 in a subset of HIV-1 elite controllers.

Riveira-Muñoz E, Ruiz A, Pauls E, Permanyer M, Badia R, Mothe B, Crespo M, Clotet B, Brander C, Ballana E, Esté JA.

J Antimicrob Chemother. 2014 Nov;69(11):3057-60. doi: 10.1093/jac/dku276. Epub 2014 Jul 25.

PMID:
25063780
24.

Palbociclib, a selective inhibitor of cyclin-dependent kinase4/6, blocks HIV-1 reverse transcription through the control of sterile α motif and HD domain-containing protein-1 (SAMHD1) activity.

Pauls E, Badia R, Torres-Torronteras J, Ruiz A, Permanyer M, Riveira-Muñoz E, Clotet B, Marti R, Ballana E, Esté JA.

AIDS. 2014 Sep 24;28(15):2213-22. doi: 10.1097/QAD.0000000000000399.

PMID:
25036183
25.

Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells.

Pauls E, Ruiz A, Badia R, Permanyer M, Gubern A, Riveira-Muñoz E, Torres-Torronteras J, Alvarez M, Mothe B, Brander C, Crespo M, Menéndez-Arias L, Clotet B, Keppler OT, Martí R, Posas F, Ballana E, Esté JA.

J Immunol. 2014 Aug 15;193(4):1988-97. doi: 10.4049/jimmunol.1400873. Epub 2014 Jul 11.

26.

Exploring the role of 2-chloro-6-fluoro substitution in 2-alkylthio-6-benzyl-5-alkylpyrimidin-4(3H)-ones: effects in HIV-1-infected cells and in HIV-1 reverse transcriptase enzymes.

Rotili D, Tarantino D, Nawrozkij MB, Babushkin AS, Botta G, Marrocco B, Cirilli R, Menta S, Badia R, Crespan E, Ballante F, Ragno R, Esté JA, Maga G, Mai A.

J Med Chem. 2014 Jun 26;57(12):5212-25. doi: 10.1021/jm500284x. Epub 2014 Jun 16.

PMID:
24933420
27.

SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors.

Ballana E, Badia R, Terradas G, Torres-Torronteras J, Ruiz A, Pauls E, Riveira-Muñoz E, Clotet B, Martí R, Esté JA.

Antimicrob Agents Chemother. 2014 Aug;58(8):4804-13. doi: 10.1128/AAC.03145-14. Epub 2014 Jun 9.

28.

Zinc finger endonuclease targeting PSIP1 inhibits HIV-1 integration.

Badia R, Pauls E, Riveira-Munoz E, Clotet B, Esté JA, Ballana E.

Antimicrob Agents Chemother. 2014 Aug;58(8):4318-27. doi: 10.1128/AAC.02690-14. Epub 2014 May 12.

29.

New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.

Famiglini V, La Regina G, Coluccia A, Pelliccia S, Brancale A, Maga G, Crespan E, Badia R, Clotet B, Esté JA, Cirilli R, Novellino E, Silvestri R.

Eur J Med Chem. 2014 Jun 10;80:101-11. doi: 10.1016/j.ejmech.2014.04.027. Epub 2014 Apr 12.

PMID:
24769348
30.

Gene editing using a zinc-finger nuclease mimicking the CCR5Δ32 mutation induces resistance to CCR5-using HIV-1.

Badia R, Riveira-Muñoz E, Clotet B, Esté JA, Ballana E.

J Antimicrob Chemother. 2014 Jul;69(7):1755-9. doi: 10.1093/jac/dku072. Epub 2014 Mar 20.

PMID:
24651827
31.

p21 regulates the HIV-1 restriction factor SAMHD1.

Pauls E, Ruiz A, Riveira-Muñoz E, Permanyer M, Badia R, Clotet B, Keppler OT, Ballana E, Este JA.

Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):E1322-4. doi: 10.1073/pnas.1322059111. Epub 2014 Mar 7. No abstract available.

32.

The cortical actin determines different susceptibility of naïve and memory CD4+ T cells to HIV-1 cell-to-cell transmission and infection.

Permanyer M, Pauls E, Badia R, Esté JA, Ballana E.

PLoS One. 2013 Nov 11;8(11):e79221. doi: 10.1371/journal.pone.0079221. eCollection 2013.

33.

Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.

Tintori C, Selvaraj M, Badia R, Clotet B, Esté JA, Botta M.

ChemMedChem. 2013 Mar;8(3):475-83. doi: 10.1002/cmdc.201200584. Epub 2013 Feb 12.

PMID:
23404750
34.

The influence of dietary locust bean gum and live yeast on some digestive immunological parameters of piglets experimentally challenged with Escherichia coli.

Badia R, Lizardo R, Martinez P, Badiola I, Brufau J.

J Anim Sci. 2012 Dec;90 Suppl 4:260-2. doi: 10.2527/jas.53894.

PMID:
23365349
35.

Oligosaccharide structure determines prebiotic role of β-galactomannan against Salmonella enterica ser. Typhimurium in vitro.

Badia R, Lizardo R, Martinez P, Brufau J.

Gut Microbes. 2013 Jan-Feb;4(1):72-5. doi: 10.4161/gmic.22728. Epub 2012 Nov 8.

36.

Trans-infection but not infection from within endosomal compartments after cell-to-cell HIV-1 transfer to CD4+ T cells.

Permanyer M, Ballana E, Badia R, Pauls E, Clotet B, Esté JA.

J Biol Chem. 2012 Sep 14;287(38):32017-26. doi: 10.1074/jbc.M112.343293. Epub 2012 Jul 30.

37.

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

Ballana E, Riveira-Munoz E, Pou C, Bach V, Parera M, Noguera M, Santos JR, Badia R, Casadellà M, Clotet B, Paredes R, Martínez MA, Brander C, Esté JA.

Immunobiology. 2013 Apr;218(4):543-7. doi: 10.1016/j.imbio.2012.06.012. Epub 2012 Jun 28.

PMID:
22818666
38.

Antiretroviral agents effectively block HIV replication after cell-to-cell transfer.

Permanyer M, Ballana E, Ruiz A, Badia R, Riveira-Munoz E, Gonzalo E, Clotet B, Esté JA.

J Virol. 2012 Aug;86(16):8773-80. doi: 10.1128/JVI.01044-12. Epub 2012 Jun 13.

39.

Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals.

Ballana E, Ruiz-de Andres A, Mothe B, Ramirez de Arellano E, Aguilar F, Badia R, Grau E, Clotet B, del Val M, Brander C, Esté JA.

Immunobiology. 2012 Sep;217(9):889-94. doi: 10.1016/j.imbio.2011.12.012. Epub 2012 Jan 8.

PMID:
22333575
40.

β-Galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cells.

Badia R, Brufau MT, Guerrero-Zamora AM, Lizardo R, Dobrescu I, Martin-Venegas R, Ferrer R, Salmon H, Martínez P, Brufau J.

Clin Vaccine Immunol. 2012 Mar;19(3):368-76. doi: 10.1128/CVI.05532-11. Epub 2012 Feb 1.

41.

Effect of Saccharomyces cerevisiae var. Boulardii and β-galactomannan oligosaccharide on porcine intestinal epithelial and dendritic cells challenged in vitro with Escherichia coli F4 (K88).

Badia R, Zanello G, Chevaleyre C, Lizardo R, Meurens F, Martínez P, Brufau J, Salmon H.

Vet Res. 2012 Jan 25;43:4. doi: 10.1186/1297-9716-43-4.

42.

Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1.

González-Ortega E, Ballana E, Badia R, Clotet B, Esté JA.

Antiviral Res. 2011 Dec;92(3):479-83. doi: 10.1016/j.antiviral.2011.10.010. Epub 2011 Oct 18.

PMID:
22027647
43.

The effect of oxidative environment on immunosuppressive properties of human seminal plasma.

Badia R, Iborra A, Palacio JR, Antich M, Martínez P.

Am J Reprod Immunol. 2008 Oct;60(4):354-60. doi: 10.1111/j.1600-0897.2008.00634.x.

PMID:
19046142
44.

Molecularly imprinted sol-gels for nafcillin determination in milk-based products.

Guardia L, Badía R, Díaz-García ME.

J Agric Food Chem. 2007 Feb 7;55(3):566-70.

PMID:
17263442
45.

The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients.

Palacio JR, Iborra A, Ulcova-Gallova Z, Badia R, Martínez P.

Clin Exp Immunol. 2006 May;144(2):217-22.

46.

Molecular imprinted ormosils for nafcillin recognition by room temperature phosphorescence optosensing.

Guardia L, Badía R, Díaz-García ME.

Biosens Bioelectron. 2006 Mar 15;21(9):1822-9. Epub 2005 Nov 4.

PMID:
16275054
47.

Insights into the reaction of beta-lactam antibiotics with copper(II) ions in aqueous and micellar media: kinetic and spectrometric studies.

Fernández-González A, Badía R, Díaz-García ME.

Anal Biochem. 2005 Jun 1;341(1):113-21.

PMID:
15866535
48.

Fluorometric monitoring of organic reactions on solid phase.

Pina-Luis G, Badía R, Díaz-García ME, Rivero IA.

J Comb Chem. 2004 May-Jun;6(3):391-7.

PMID:
15132599
49.
50.

Quantitative aspects of drugs of abuse in urine samples: intercollaborative studies conducted in the European Union.

Corcione S, Pichini S, Badia R, Segura J, de la Torre R.

Ther Drug Monit. 1999 Dec;21(6):653-60.

PMID:
10604828

Supplemental Content

Support Center